TXG News and Press, 10x Genomics Inc. From 02/14/23

10x Genomics ( NASDAQ: TXG ) is scheduled to announce Q4 earnings results on Wednesday, February 15th, after market close. The consensus EPS Estimate is -$0.20 (-25.0% Y/Y) and the consensus Revenue Estimate is $148.17M (+3.3% Y/Y). Over the last 1 year, TXG has beaten EPS e...

(All amounts expressed in US. Dollars unless otherwise stated) TORONTO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) provides an inaugural quarterly update on the development of its Media Luna Project (“...

10x Genomics Demonstrates Breadth, Scale and Leadership at 2023 AGBT General Meeting PR Newswire Showcases unique power and scalability of Chromium Flex across fresh, frozen and FFPE samples, including data from an 8 million cell experiment on a single run Reinforces perfo...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips CRISPR is an acronym which refers to a series of DNA sequences in bacteria and other organisms. Scientists have begun editing genes, including CRISPR,  to try to improve human health. Using CRISPR, scientists can slice int...

Summary Baillie Gifford’s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. They increased NVIDIA, Shopify, NIO Inc., SEA Ltd., Roblox, DoorDash, and Ginkgo Bioworks while reducing Illumina, Ferrari N.V., Arthur J. Gallagher & Co., Albemarle, Meta Platform...

Summary ARK Invest’s 13F portfolio value decreased from $14.35B to $11.54B this quarter. They increased Tesla, Ginkgo Bioworks, and Coinbase Global stakes while decreasing NVIDIA, Fate Therapeutics, and TuSimple Holdings during the quarter. The top three positions are Exact S...

Summary Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. When the end to restrictive policy is in sight, then the sector is likely to witness a group rotation to more growth-oriented stocks. Groups like medical d...

10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023 PR Newswire PLEASANTON, Calif. , Jan. 19, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and f...

Summary Pharmaceuticals and biotechnology have the best value and quality scores in the sector. Healthcare providers are close to their historical baseline in valuation and quality. Fast facts on GNOM. 10 stocks cheaper than their peers in January. This monthly article...

Summary Bruker offers a range of advantages over peers: profitability, value, growth, and more. As such, the company is well-positioned to provide strong returns in the future. This article will address recent developments, highlight the advantages, and discuss the opportunity. ...